113 items found

Tags: Pharmacology Science Policy placebo

Filter Results
  • dataset

    Safety and Efficacy of Botulinum Toxin to Preserve Gland Function after Radio...

    This prospective, randomized, placebo-controlled, double-blinded phase I clinical trial investigates safety and efficacy of botulinum toxin (BoNT) to preserve gland function...
  • dataset

    r37980778c78--8303411f52e6926de4e649bf1884fd74

    Summary of treatment effects compared with placebo.
  • dataset

    r37980778c78--35cd39301259e32224036ee6742db00a

    Detailed analysis of randomized-controlled trials evaluating steroids in neonates.
  • dataset

    Summary of safety assessment.

    Summary of safety assessment.
  • dataset

    r37980778c78--8de4153ca91984adb0d1863a10029fea

    Baseline correlates of participant retention at clinic visits and at the delivery visit.
  • dataset

    Classification of the placebo–controlled drug trials in neonates in ClinicalT...

    Classification of the placebo–controlled drug trials in neonates in ClinicalTrials.gov (1999–2015) according to design and aim.
  • dataset

    r37980778c78--c4357ab0365ee84b8f65487b60a5bf2a

    Human intervention study volunteer stratification into groups according to baseline total cholesterol, age and gender in the active (Lactobacillus plantarum ECGC 13110402) and...
  • dataset

    r37980778c78--9ac6003cd8189ede6776e51986ca0852

    Number of included patients, mean difference and heterogeneity in meta-analyses of double blind, randomised controlled trials comparing SGLT2-i versus oral antidiabetic drugs.
  • dataset

    Network meta-analysis for efficacy and safety of commonly prescribed medicati...

    Network meta-analysis for efficacy and safety of commonly prescribed medications compared with methylphenidate.
  • dataset

    r37980778c78--e428aff683e3566e8b669645bf74a403

    Botulism neurotoxins are highly toxic and are potential agents for bioterrorism. The development of effective therapy is essential to counter the possible use of these toxins in...
  • dataset

    r37980778c78--f52f046efab5ded35c2958d54fcadea9

    In 1st endpoint analysis, the group of BRC treatment tended to be recovered compared to the group of placebo treatment. Moreover, in 2nd endpoint analysis, the group of BRC was...
  • dataset

    Subject characteristics in varenicline and placebo groups.

    N = 87 (varenicline N = 42, placebo N = 45) based on subjects who had one post baseline reading on at least one outcome variable. Actual N's for some variables are lower because...
  • dataset

    Patient characteristics at baseline.

    ║PC20 methacholine is expressed as geometric mean (standard deviation in doubling dose (DD)). ‡range 1 to 5 (higher scores indicate more dyspnea); †range 0 (best) to 100...
  • dataset

    Univariate and multivariable regression models at Hour 0.

    Univariate and multivariable regression models at Hour 0.
  • dataset

    r37980778c78--f46f9d9999feadd35408654491588581

    Severe thrombocytopenia in dengue often prompts platelet transfusion primarily to reduce bleeding risk. In India, about 11–43% of dengue patients report receiving platelet...
  • dataset

    r37980778c78--e1b6cdcac82936cfa35526be7c2335d5

    Adverse events following azithromycin treatment among infants aged 1–5 months in communities randomized to azithromycin or placebo (N = 1,712).
  • dataset

    Lipid parameters expressed in mM in all study participants between baseline a...

    Lipid parameters expressed in mM in all study participants between baseline and 12 weeks in the active (Lactobacillus plantarum ECGC 13110402) and placebo treatment groups.
  • dataset

    Subjective feelings of endurance and exertion (1–10 point scales) after a gra...

    Subjective feelings of endurance and exertion (1–10 point scales) after a graded exercise test, and perceived muscle power after a 15-s Wingate test with the administration of 3...
  • dataset

    Meta-analysis of the most frequent TEAEs with a frequency of≥5% in duloxetine...

    Meta-analysis of the most frequent TEAEs with a frequency of≥5% in duloxetine-treated patients.
  • dataset

    Outcome measures during Emergency Department stay.

    Outcome measures during Emergency Department stay.